Showing results (341-350 of 353) with videos related to
Sort By:
Pageof 36
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.International Journal of Cardiology|June 18, 2022
Validation of time-resolved, automated peak trans-mitral velocity tracking: Two center four-dimensional flow cardiovascular magnetic resonance studyPaul Njoku, Ciaran Grafton-Clarke, Hosamadin Assadi, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A Sandham, Clive Aldcroft, Urs Baettig, et al.Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.Journal of Medicinal Chemistry|March 17, 2021
Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus FusionG Stuart Cockerill, Richard M Angell, Alexandre Bedernjak, et al.Nucleic Acids Research|October 29, 2013
Ensembl Genomes 2013: scaling up access to genome-wide dataPaul Julian Kersey, James E Allen, Mikkel Christensen, et al.Plos Pathogens|September 16, 2021
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patientsJonathan Youngs, Nicholas M Provine, Nicholas Lim, et al.Nucleic Acids Research|November 19, 2015
Ensembl Genomes 2016: more genomes, more complexityPaul Julian Kersey, James E Allen, Irina Armean, et al.Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.Pageof 36